BUVIDAL 160 mg SOLUCION INYECTABLE DE LIBERACION PROLONGADA

Camurus Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e969fcd497933fe1
Drug Cima Aemps Name: BUVIDAL 160 mg SOLUCION INYECTABLE DE LIBERACION PROLONGADA
Register Number: 1181336009
Holder Company Name: Camurus Ab
Marketing Company Name: Camurus Ab
Holder Company Detail Path: /organization/camurus-ab
Marketing Company Detail Path: /organization/camurus-ab
Authorization Date: 2021-06-23
Dosage Form: SOLUCION INYECTABLE DE LIBERACION PROLONGADA
Dose: 160 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Camurus Ab
Company Detail Path: /organization/camurus-ab

BUPRENORFINA

160 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 23, 2021

Approval ID

e969fcd497933fe1

Type

Standard